329 related articles for article (PubMed ID: 8728867)
1. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA
Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867
[TBL] [Abstract][Full Text] [Related]
2. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
3. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
5. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
Berini CA; Eirin ME; Pando MA; Biglione MM
J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
Stramer SL; Foster GA; Dodd RY
Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human T-cell leukemia virus types I and II in Switzerland.
Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J;
J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
11. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
12. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
[TBL] [Abstract][Full Text] [Related]
13. Blood safety strategies for human T-cell lymphotropic virus in Europe.
Laperche S; Worms B; Pillonel J; ;
Vox Sang; 2009 Feb; 96(2):104-10. PubMed ID: 19076337
[TBL] [Abstract][Full Text] [Related]
14. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
15. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance.
Urwijitaroon Y; Barusrux S; Puapairoj C; Romphruk A; Khampeera P
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S102-5. PubMed ID: 9347655
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
